The epidemiology of bone cancer in 0-39 year olds in northern England, 1981-2002

被引:30
作者
Eyre, Rachel [1 ]
Feltbower, Richard G. [2 ]
James, Peter W. [1 ]
Blakey, Karen [1 ]
Mubwandarikwa, Emmanuel [1 ]
Forman, David [3 ,4 ,5 ,6 ]
McKinney, Patricia A. [2 ]
Pearce, Mark S. [1 ]
McNally, Richard J. Q. [1 ]
机构
[1] Newcastle Univ, Royal Victoria Infirm, Inst Hlth & Soc, Sir James Spence Inst, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[2] Univ Leeds, Paediat Epidemiol Grp, Ctr Biostat & Epidemiol, Leeds LS2 9JT, W Yorkshire, England
[3] Univ Leeds, No & Yorkshire Canc Registry, Leeds LS9 7TF, W Yorkshire, England
[4] Univ Leeds, Informat Serv, Leeds LS9 7TF, W Yorkshire, England
[5] Leeds Inst Genet Hlth & Therapeut, Canc Epidemiol Grp, Leeds LS16 6QB, W Yorkshire, England
[6] Int Agcy Res Canc, Canc Informat Sect, F-69372 Lyon 08, France
关键词
PROGNOSTIC-FACTORS; EWINGS-SARCOMA; SURVIVAL; TUMORS; OSTEOSARCOMA; ADOLESCENTS; CHEMOTHERAPY; IFOSFAMIDE; PATTERNS; CHILDREN;
D O I
10.1186/1471-2407-10-357
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: There is a paucity of recent epidemiological data on bone cancers. The aim of this study was to describe incidence and survival patterns for bone cancers diagnosed during 1981 - 2002. Methods: Cases aged 0 - 39 years (236 osteosarcomas, 166 Ewing sarcomas and 73 chondrosarcomas) were analysed using Poisson and Cox regressions. Results: Incidence rates (per million persons per year) for osteosarcoma were 2.5 at age 0 - 14 years; 4.5 at age 15 - 29 years and 1.0 at age 30 - 39 years. Similarly, for Ewing sarcoma the incidence rates were 2.2; 2.9; 0.4 and for chondrosarcoma rates were 0.1; 1.2; 1.8 respectively. Incidence of osteosarcoma increased at an average annual rate of 2.5% (95% CI 0.4 - 4.7; P = 0.02), but there was no change in incidence of Ewing sarcoma or chondrosarcoma. There was a marginally statistically significant improvement in survival for Ewing sarcoma (hazard ratio (HR) per annum = 0.97; 95% CI 0.94 - 1.00; P = 0.06), although patients aged 15 - 39 years (n = 93) had worse overall survival than those aged 0 - 14 (n = 73; HR = 1.46; 95% CI 0.98 - 2.17; P = 0.06). There was no significant improvement in osteosarcoma survival (HR per annum = 0.98; 95% CI 0.95 - 1.01; P = 0.18). Conclusions: Reasons for poorer survival in Ewing sarcoma patients aged 15 - 39 years and failure to significantly improve survival for osteosarcoma patients requires further investigation.
引用
收藏
页数:7
相关论文
共 40 条
[1]  
AJIKI W, 1971, JPN J CANCER RES, V139, P1988
[2]  
Altekruse SFKC, 1975, SEER CANC STAT REV 1
[3]  
[Anonymous], 1960, CANC MORTALITY SELEC
[4]   Up-to-date monitoring of childhood cancer long-term survival in Europe: tumours of the sympathetic nervous system, retinoblastoma, renal and bone tumours, and soft tissue sarcomas [J].
Arndt, V. ;
Lacour, B. ;
Steliarova-Foucher, E. ;
Spix, C. ;
Znaor, A. ;
Pastore, G. ;
Stiller, C. ;
Brenner, H. .
ANNALS OF ONCOLOGY, 2007, 18 (10) :1722-1733
[5]   Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: Analysis of 359 patients at the Istituto Ortopedico Rizzoli [J].
Bacci, G ;
Ferrari, S ;
Bertoni, F ;
Rimondini, S ;
Longhi, A ;
Bacchini, P ;
Forni, C ;
Manfrini, M ;
Donati, D ;
Picci, P .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) :4-11
[6]  
BRAY F, 2002, CANC INCIDENCE FIVE
[7]  
Carsi B, 2002, CLIN ORTHOP RELAT R, P53
[8]  
Coleman M., 1993, IARC Scientific Publications, V121
[9]   Prognostic factors in Ewing's tumor of bone:: Analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study group [J].
Cotterill, SJ ;
Ahrens, S ;
Paulussen, M ;
Jürgens, HF ;
Voûte, PA ;
Gadner, H ;
Craft, AW .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) :3108-3114
[10]  
COTTERILL SJ, 1968, BRIT J CANCER, V83, P397